|
Completed
|
NCT04112953 -
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
|
|
|
Completed
|
NCT04395911 -
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections
|
N/A |
|
Terminated
|
NCT04530448 -
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
|
Phase 4 |
|
Active, not recruiting
|
NCT04008810 -
Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
|
|
|
Recruiting
|
NCT04597034 -
Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19
|
N/A |
|
Completed
|
NCT04458571 -
Effect of CRRT Duration on Solute Removal
|
|
|
Recruiting
|
NCT04114747 -
Renal Physiology During Continuous Renal Replacement Therapy
|
N/A |
|
Completed
|
NCT05094154 -
Effect of Antibiotic Choice On ReNal Outcomes (ACORN)
|
Phase 4 |
|
Enrolling by invitation
|
NCT04491227 -
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
|
|
|
Not yet recruiting
|
NCT05382078 -
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
|
|
|
Recruiting
|
NCT04351906 -
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome
|
N/A |
|
Completed
|
NCT04762524 -
The Impact of CRRT Modality on Filter Life
|
N/A |
|
Completed
|
NCT04048525 -
Cytokine Removal With CVVHD Compared to CVVH
|
N/A |
|
Completed
|
NCT04788394 -
Renal Involvement in Hospitalized Children With COVID-19
|
|
|
Recruiting
|
NCT04474249 -
Follow-up of Critical COVID-19 Patients
|
|
|
Recruiting
|
NCT04517630 -
Renal Biomarkers in AKI and COVID-19
|
|
|
Completed
|
NCT04407156 -
Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom
|
|
|
Recruiting
|
NCT04895384 -
El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)
|
|
|
Completed
|
NCT03070353 -
Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury
|
Phase 2/Phase 3 |
|
Completed
|
NCT03391830 -
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
|
N/A |